News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sepracor, Inc. (SEPR) Release: Data For XOPENEX(R) Brand Of Levalbuterol Presented At American College of Chest Physicians Annual Conference



10/23/2006 12:22:33 PM

MARLBOROUGH, Mass.--(BUSINESS WIRE)--Sepracor Inc. (Nasdaq: SEPR) today announced the presentation of posters of clinical data from studies of XOPENEX HFA® (levalbuterol tartrate) Inhalation Aerosol and XOPENEX® (levalbuterol HCl) Inhalation Solution at CHEST 2006, the annual meeting of the American College of Chest Physicians (ACCP), in Salt Lake City.

Read at BioSpace.com


comments powered by Disqus
   
Asthma

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES